CORT Corcept Therapeutics Inc

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

$21.03  -0.09 (-0.43%)
As of 11/30/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/14/2004
Outstanding shares:  115,451,895
Average volume:  870,640
Market cap:   $2,481,061,224
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    218352102
ISIN:        US2183521028
Sedol:      B00SCY1
Valuation   (See tab for details)
PE ratio:   22.91
PB ratio:   4.51
PS ratio:   7.03
Return on equity:   19.71%
Net income %:   30.17%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy